
Keywords: Malaria; Naturally acquired immunity; Vaccine; Uganda; WGCFS; wheat germ cell free system; ASC; AlphaScreen Counts; IQR; interquartile range; PPE; potential protective efficacy; MSP6; merozoite surface protein 6; AMA1; apical membrane antigen 1; CSP; circ